Displaying 37 - 48 of 288
Metabolism, Alcohol & Toxicity

Kickoff: The importance of early screening

Webcasts
View
Metabolism, Alcohol & Toxicity

MASLD – current treatment  strategies  - from metabolic indices to patient reported outcomes

Webcasts
View
Metabolism, Alcohol & Toxicity

Focusing on metabolic risk of MASLD. EXCEL study design and major outcomes

Webcasts
View
Metabolism, Alcohol & Toxicity

Understanding burden of  MASLD: The Importance  on Quality of Life

Webcasts
View
Metabolism, Alcohol & Toxicity

Panel discussion

Webcasts
View
Metabolism, Alcohol & Toxicity

Pathophysiological analysis of MASH: targetting clinical manifestations

Webcasts
View
Metabolism, Alcohol & Toxicity

Novo Nordisk: Addressing MASH as a liver manifestation of the metabolic disease (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Approaching MASH as a metabolic disease with the need for holistic therapy

Webcasts
View
Metabolism, Alcohol & Toxicity

Panel Discussion

Webcasts
View
Metabolism, Alcohol & Toxicity

Summary and Closing remarks

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Cholestatic Pruritus in Primary Biliary Cholangitis (PBC): Assessment and Management Guide

Cholestatic Pruritus in Primary Biliary Cholangitis (PBC): Assessment and Management Guide

Infographics
View
Immune-Mediated and Cholestatic Diseases
Current Therapies: Patients with PBC Pruritus

Current Therapies: Patients with PBC Pruritus

Webcasts
View
Displaying 37 - 48 of 288